Virginia Mason Medical Center
Also known as: Benaroya Research Institute | Benaroya Research Institute at Virginia Mason | Benaroya Research Institute at Virginia Mason: Diabetes Research Program | Carla Greenbaum, MD | Christine Oryhan | Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center | Virginia Mason Hospital/Medical Center | Virginia mason medical Center | Virginia Mason Medical Center | Virginia Mason Medical Center - Benaroya Research Institute | Virginia Mason Medical Center, Departments of Urology and Anesthesiology | Virginia Mason Medical Centre, WA USA | Virginia Mason Memorial Hospital
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2003Last known activity
Sep 13, 2024
Timeline
1920s
- Jun 1, 1920
Virginia Mason Medical Center— Founded
Drugs by trial phase (65 distinct, 43 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (43 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Neoplasms
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Burkitt Lymphoma
- Carcinoma, Ovarian Epithelial
- Cholangiocarcinoma
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Delirium
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Fallopian Tube Neoplasms
- Lower Urinary Tract Symptoms
- Lymphoma
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Peritoneal Neoplasms
- Polychondritis, Relapsing
- Postoperative Pain
- Prostatic Neoplasms
- Rectal Neoplasms
- Ulcer
Recent trials (50)
- NCT06585540Sponsor investigatorPhase 3Sep 13, 2024
- NCT06585540OfficialPhase 3Sep 13, 2024
- NCT06585540CollaboratorPhase 3Sep 13, 2024
- NCT06585540Lead sponsorPhase 3Sep 13, 2024
- NCT05868993Lead sponsorPhase 4Feb 17, 2023
- NCT05281614Lead sponsorEarly Phase 1Aug 1, 2022
- NCT04668976CollaboratorPhase 2Nov 25, 2020
- NCT04668976Overall official - principal investigatorPhase 2Nov 25, 2020
- NCT04668976Lead sponsorPhase 2Nov 25, 2020
- NCT05847413Overall official - principal investigatorEarly Phase 1May 30, 2020
- NCT05847413Lead sponsorEarly Phase 1May 30, 2020
- NCT04417699CollaboratorPhase 2Apr 1, 2020
- NCT04417699Lead sponsorPhase 2Apr 1, 2020
- NCT04417699Overall official - principal investigatorPhase 2Apr 1, 2020
- NCT04118153Overall official - principal investigatorEarly Phase 1Dec 31, 2019
Details
- Founded
- Seattle, WA, US Jun 1, 1920
- Last known activity
- Sep 13, 2024